- Home
- HFWA vs OCS Comparison
HFWA vs OCS Comparison
Compare HFWA & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFWA
- OCS
- Stock Information
- Founded
- HFWA 1927
- OCS 2003
- Country
- HFWA United States
- OCS Switzerland
- Employees
- HFWA N/A
- OCS N/A
- Industry
- HFWA Banks
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- HFWA Finance
- OCS Health Care
- Exchange
- HFWA Nasdaq
- OCS Nasdaq
- Market Cap
- HFWA 800.3M
- OCS 706.3M
- IPO Year
- HFWA N/A
- OCS N/A
- Fundamental
- Price
- HFWA $26.16
- OCS $14.14
- Analyst Decision
- HFWA Buy
- OCS Strong Buy
- Analyst Count
- HFWA 5
- OCS 5
- Target Price
- HFWA $24.40
- OCS $29.20
- AVG Volume (30 Days)
- HFWA 216.6K
- OCS 73.4K
- Earning Date
- HFWA 10-24-2024
- OCS 11-07-2024
- Dividend Yield
- HFWA 3.52%
- OCS N/A
- EPS Growth
- HFWA N/A
- OCS N/A
- EPS
- HFWA 1.08
- OCS N/A
- Revenue
- HFWA $203,985,000.00
- OCS $1,027,571.00
- Revenue This Year
- HFWA N/A
- OCS $4.38
- Revenue Next Year
- HFWA $9.22
- OCS $905.09
- P/E Ratio
- HFWA $24.26
- OCS N/A
- Revenue Growth
- HFWA N/A
- OCS N/A
- 52 Week Low
- HFWA $16.55
- OCS $9.60
- 52 Week High
- HFWA $27.55
- OCS $18.00
- Technical
- Relative Strength Index (RSI)
- HFWA 66.29
- OCS 37.01
- Support Level
- HFWA $22.28
- OCS $16.44
- Resistance Level
- HFWA $27.10
- OCS $18.00
- Average True Range (ATR)
- HFWA 0.87
- OCS 0.68
- MACD
- HFWA 0.18
- OCS -0.46
- Stochastic Oscillator
- HFWA 73.62
- OCS 3.50
About HFWA Heritage Financial Corporation
Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.